Sanofi transfers vaccine production technology to VNVC

The signing ceremony was attended by President Luong Cuong and French President Emmanuel Macron as part of the latter's state visit to Vietnam from May 25–27.

According to the cooperation agreement, VNVC and Sanofi will progressively transfer technology to produce several important Sanofi vaccines in Vietnam. In addition, Sanofi will support VNVC in human resource training and quality management related to vaccine research and production. The technology will be transferred to the VNVC Vaccine and Biological Products Factory in Long An, which is scheduled to begin construction this year.

Ngo Chi Dung (L, 3rd), Chairman and CEO of Vietnam Vaccine Company (VNVC), and Zainab Sadat Qayyum (L, 2nd), President of Sanofi Southeast Asia-India, exchange documents on the cooperation agreement, witnessed by President Luong Cuong (R) and President Emmanuel Macron (L). Photo by Lam Khanh

Ngo Chi Dung, Chairman and CEO of VNVC, said this collaboration is significant, as it enables VNVC and Vietnam's vaccine production industry to quickly improve their capabilities. The technology transfer will facilitate access to leading modern technologies, optimize research and development processes, and promptly address domestic healthcare needs.

Dung noted that the agreement gives Vietnam the opportunity to access world-class vaccine production technology, allowing VNVC to produce hundreds of millions of high-quality vaccine doses each year for both domestic use and export, while also reducing costs for the public. "This is a crucial step in the strategy for vaccine coverage, strengthening national healthcare security, and improving the quality of life for the community," he said.

A man gets vaccinated at VNVC. Photo by Moc Thao

The VNVC Vaccine and Biological Products Factory will cover up to 26,000 sq m, with an initial investment of VND2 trillion (US$77.16 million). The facility is designed to meet the highest Good Manufacturing Practice (GMP) standards set by the World Health Organization (WHO), the European Union (EU), and the U.S. Food and Drug Administration (FDA).

Sanofi is one of the world's leading pharmaceutical manufacturers. In Vietnam, Sanofi provides tens of millions of high-quality vaccine doses, including Hexaxim (6-in-1), Tetraxim (4-in-1), Adacel (3-in-1), Verorab rabies vaccine, Menactra meningococcal vaccine, and Avaxim hepatitis A vaccine. Most of these vaccines are distributed and administered through VNVC's network of over 220 vaccination centers nationwide.